Viking Therapeutics (VKTX) Misses Q2 EPS by 1c

Viking Therapeutics (NASDAQ: VKTX) reported Q2 EPS of ($0.21), $0.01 worse than the analyst estimate of ($0.20).

For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• FedEx (FDX) Tops Q4 EPS by 39c, Beats on Revenue; Offers FY27 EPS Guidance
• KB Home (KBH) Misses Q2 EPS by 2c; Offers Outlook